Home Pregenen

Pregenen

acquired
Undisclosed
New Generation Cell Gene Therapy Technology Company
Basic
Enterprise Profile

Basic Information

Pregenen designs and engineers molecules that are crucial for the next generation of cell-based therapies, addressing unmet medical needs. We collaborate with our partners to apply our tools, services, and reagents, enhancing the reliability, efficacy, and safety of a new wave of therapies that leverage the specificity and functional capabilities of molecules and cells produced by the human body.
Pregenen
Seattle,Washington,United States of America
unclear
January 01, 2006
info@bluebirdbio.com

Enterprise Profile

Industrial Sector
Biological Product Manufacturing # Diagnostic Manufacturing
Technology
Gene Technology In Vitro Diagnostics
Concept
Disease Treatment